Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapy: immunopharmaceuticals].

G Mahrle

    Zeitschrift Fur Hautkrankheiten
    |May 15, 1987
    PubMed
    Summary
    This summary is machine-generated.

    This review classifies immunopharmacological agents, including novel drugs like recombinant interleukin 2 and established treatments such as Levamisole, highlighting their potential effects on the immune system.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [In honor of Professor Dr. Dr. h.c. G. K. Steigleder on the occasion of his 90th birthday].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2015
    Same author

    Vasoactive-intestinal-Peptide (vip) modulates the growth fraction of epithelial skin cells.

    International journal of oncology·2011
    Same author

    Dermal absorption of permethrin following topical administration.

    European journal of clinical pharmacology·2005
    Same author

    [Multiple autoimmune syndrome. Reynolds-syndrome (acral scleroderma, primary biliary cirrhosis, Sjögren syndrome) associated with the lupus erythematosus/lichen planus overlap syndrome].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2004
    Same author

    Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.

    American journal of clinical dermatology·2001
    Same author

    Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test.

    Skin pharmacology and applied skin physiology·2001
    Same journal

    [Acne vulgaris: morphologic, endocrinologic and psychosomatic aspects].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Anti-androgen treatment of hirsutism with cyproterone acetate].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Changes in sunscreening products in West Germany between 1988 and 1989/90].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Effect of treatment with salt from the Dead Sea (Tomesa therapy) on epidermal Langerhans cells--a clinical study].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [DNA determination by cytophotometry in bowenoid papules in comparison with condylomata acuminata and Bowen's disease].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Adverse drug reactions on hair].

    Zeitschrift fur Hautkrankheiten·1990
    See all related articles

    Area of Science:

    • Immunopharmacology
    • Immunomodulation
    • Drug Discovery

    Context:

    • The field of immunopharmacology encompasses diverse agents that modulate immune responses.
    • Understanding these agents is crucial for developing new therapeutic strategies.
    • Existing classifications provide a framework for organizing immunomodulatory substances.

    Purpose:

    • To classify existing and emerging immunopharmacological agents.
    • To provide an overview of key drugs and substances affecting the immune system.
    • To highlight novel immunomodulators and their therapeutic potential.

    Summary:

    • Immunopharmacological agents are categorized into thymus factors, lymphokines/cytokines, microbial products, potential immune-modifying drugs, and external immunomodulators.

    Related Experiment Videos

  • The review discusses novel substances including Timunox, Tp-1 Serono, delimmun, Isoprenosine, recombinant interleukin 2, Immuneron, tumor necrosis factor, Sandimmun, and diphencyprone.
  • Established drugs like Levamisole, Bestatin, gold compounds, sulfones, and sulfopyridines are also reviewed.

    • Impact:

    • Provides a comprehensive classification of immunomodulatory agents.
    • Facilitates understanding of the landscape of immunopharmacology.
    • Informs future research and development in immune system modulation and drug discovery.